SCHEMBL14963311

SCHEMBL14963311

CC(C)(C)n1nc(CN2CCC3(CC2)CN(c2ccccc2)C(=O)O3)c2cc(Cl)c(F)cc21

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SSTR5 P35346 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14957622 0.91 SSTR5 (1.00) SSTR5
SCHEMBL14963296 0.78 SSTR5 (0.84) SSTR5
SCHEMBL14963290 0.76 SSTR5 (0.83) SSTR5
SCHEMBL14963291 0.74 SSTR5 (0.84) SSTR5
SCHEMBL14963321 0.73 SSTR5 (0.87) SSTR5
SCHEMBL14963297 0.71 SSTR5 (0.84) SSTR5
SCHEMBL14963312 0.71 SSTR5 (0.74) SSTR5
SCHEMBL14963301 0.71 SSTR5 (0.88) SSTR5
SCHEMBL14963325 0.71 SSTR5 (0.84) SSTR5
SCHEMBL14963453 0.71 SIGMAR1 (0.61) SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8742110-B2 Spiroxazolidinone compounds MERCK SHARP & DOHME CORP. (US) 2014-06-03 — — US disclosed
US-20130131042-A1 SPIROXAZOLIDINONE COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2013-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131042-A1 SPIROXAZOLIDINONE COMPOUNDS SSTR5, SSTR2, SSTR4 SSTR5 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback